Literature DB >> 21054337

The Electro-Mechanical window: a risk marker for Torsade de Pointes in a canine model of drug induced arrhythmias.

H J van der Linde1, B Van Deuren, Y Somers, B Loenders, R Towart, D J Gallacher.   

Abstract

BACKGROUND AND
PURPOSE: In cardiovascular pharmacology, electrical and mechanical events can be distinguished, and the phrase 'electro-mechanical window' (EMw) describes the temporal difference between these events. We studied whether changes in EMw have potential predictive value for the occurrence of arrhythmias in fentanyl/etomidate-anaesthetized beagle (FEAB) dogs. EXPERIMENTAL APPROACH: The EMw was calculated as differences between the QT interval and QLVP(end) in FEAB dogs during atrial pacing, treatment with isoprenaline or atropine, body temperature changes and induction of Torsade de Pointes (TdP) in an LQT1 model. KEY
RESULTS: The electrical systole (QT interval) was shorter than the duration of the mechanical event (QLVP(end) ), providing a positive EMw. Atrial pacing, atropine or body temperature changes had no major effects on EMw, despite large changes in QT duration. However, β-adrenoceptor stimulation (with isoprenaline) decreased the EMw (from 90 to 5 ms) and in combination with HMR1556, a blocker of the slowly activating potassium current (I(Ks) ), induced a large negative EMw (-109ms) and TdP. Prevention of TdP by atenolol or verapamil was associated with a less negative EMw (-23 to -16ms). Mexiletine, a poorly effective long QT treatment, did not affect the EMw or prevent TdP induction. CONCLUSIONS AND IMPLICATIONS: The EMw is a marker, other than QT prolongation, of TdP risk in the FEAB model. Therefore, we suggest examining the EMw as a risk marker in cardiovascular safety studies and as a potential biomarker to improve clinical management of long QT syndrome patients, especially in patients with borderline QT prolongation.
© 2010 Johnson & Johnson Pharmaceutical Research and Development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054337      PMCID: PMC3010558          DOI: 10.1111/j.1476-5381.2010.00934.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Gene specific therapy for arrhythmogenic disorders.

Authors:  S G Priori; E Ronchetti; M Memmi
Journal:  Ital Heart J       Date:  2000-09

2.  Long QT syndrome, a purely electrical disease? Not anymore.

Authors:  Gaetano M De Ferrari; Peter J Schwartz
Journal:  Eur Heart J       Date:  2009-01-16       Impact factor: 29.983

3.  Autonomic nervous system influences on QT interval in normal subjects.

Authors:  Anthony R Magnano; Steve Holleran; Rajasekhar Ramakrishnan; James A Reiffel; Daniel M Bloomfield
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

4.  Mechanoelectrical feedback: role of beta-adrenergic receptor activation in mediating load-dependent shortening of ventricular action potential and refractoriness.

Authors:  B B Lerman; E D Engelstein; D Burkhoff
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

5.  Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications.

Authors:  Hanno L Tan; Abdennasser Bardai; Wataru Shimizu; Arthur J Moss; Eric Schulze-Bahr; Takashi Noda; Arthur A M Wilde
Journal:  Circulation       Date:  2006-11-06       Impact factor: 29.690

Review 6.  The fentanyl/etomidate-anaesthetised beagle (FEAB) dog: a versatile in vivo model in cardiovascular safety research.

Authors:  Bruno Van Deuren; Karel Van Ammel; Yves Somers; Frank Cools; Roel Straetemans; Henk J van der Linde; David J Gallacher
Journal:  J Pharmacol Toxicol Methods       Date:  2009-05-05       Impact factor: 1.950

7.  In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.

Authors:  David J Gallacher; André Van de Water; Henk van der Linde; An N Hermans; Hua Rong Lu; Rob Towart; Paul G A Volders
Journal:  Cardiovasc Res       Date:  2007-06-29       Impact factor: 10.787

8.  Effects of exercise on heart rate, QT, QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome.

Authors:  G M Vincent; D Jaiswal; K W Timothy
Journal:  Am J Cardiol       Date:  1991-08-15       Impact factor: 2.778

9.  The effects of probucol on QT/QS2 relation and systolic time intervals.

Authors:  L Romics; L Littmann; Z László; T Fenyvesi
Journal:  Int J Cardiol       Date:  1988-06       Impact factor: 4.164

10.  Left ventricular mechanical dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome.

Authors:  Kristina Hermann Haugaa; Thor Edvardsen; Trond P Leren; Jon Michael Gran; Otto A Smiseth; Jan P Amlie
Journal:  Eur Heart J       Date:  2008-10-21       Impact factor: 29.983

View more
  13 in total

1.  The electro-mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes risk.

Authors:  P-J Guns; D M Johnson; J Van Op den Bosch; E Weltens; J Lissens
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  A new preclinical biomarker for risk of Torsades de Pointes: drug-induced reduction of the cardiac electromechanical window.

Authors:  Hugo M Vargas
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

3.  The electromechanical window is no better than QT prolongation to assess risk of Torsade de Pointes in the complete atrioventricular block model in dogs.

Authors:  T R G Stams; V J A Bourgonje; H D M Beekman; M Schoenmakers; R van der Nagel; P Oosterhoff; J M van Opstal; M A Vos
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 4.  The ECG vertigo in diabetes and cardiac autonomic neuropathy.

Authors:  Christina Voulgari; Nicholas Tentolouris; Christodoulos Stefanadis
Journal:  Exp Diabetes Res       Date:  2011-05-29

5.  Impact of hypokalemia on electromechanical window, excitation wavelength and repolarization gradients in guinea-pig and rabbit hearts.

Authors:  Oleg E Osadchii
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

6.  An increasing electromechanical window is a predictive marker of ventricular fibrillation in anesthetized rabbit with ischemic heart.

Authors:  Vudhiporn Limprasutr; Prapawadee Pirintr; Anusak Kijtawornrat; Robert L Hamlin
Journal:  Exp Anim       Date:  2017-11-21

7.  Combining an in silico proarrhythmic risk assay with a tPKPD model to predict QTc interval prolongation in the anesthetized guinea pig assay.

Authors:  Pierre Morissette; Sebastian Polak; Anne Chain; Jin Zhai; John P Imredy; Mary Jo Wildey; Jeffrey Travis; Kevin Fitzgerald; Patrick Fanelli; Elisa Passini; Blanca Rodriguez; Frederick Sannajust; Christopher Regan
Journal:  Toxicol Appl Pharmacol       Date:  2020-01-23       Impact factor: 4.219

8.  Drug-induced shortening of the electromechanical window is an effective biomarker for in silico prediction of clinical risk of arrhythmias.

Authors:  Elisa Passini; Cristian Trovato; Pierre Morissette; Frederick Sannajust; Alfonso Bueno-Orovio; Blanca Rodriguez
Journal:  Br J Pharmacol       Date:  2019-09-04       Impact factor: 8.739

9.  Exercise worsening of electromechanical disturbances: A predictor of arrhythmia in long QT syndrome.

Authors:  Dafni Charisopoulou; George Koulaouzidis; Annika Rydberg; Henein Y Michael
Journal:  Clin Cardiol       Date:  2018-12-22       Impact factor: 2.882

10.  Negative lusitropic property of nifekalant identified using ventricular pressure-volume loop analyses in anesthetized monkeys.

Authors:  Tomomichi Ishizaka; Yu Yoshimatsu; Yu Maeda; Katsuyoshi Chiba; Kazuhiko Mori
Journal:  Exp Anim       Date:  2018-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.